Rubra Medicaments Ltd. Share Price & Stock Analysis

Rubra Medicaments Ltd. (BSE: 531099) is a Mumbai, Maharashtra-based company in the Health Care Distributors industry. With a market capitalisation of ₹18 Cr, it ranks #4,481 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 11 in Health Care Distributors. At ₹34.99 (as of 16 Nov 2026), the share price is 74.8% below its 52-week high of ₹138.75 and 23.1% above its 52-week low of ₹28.42. The share price is down 53.2% over one year and down 35.9% over three months.

Key Metrics

Current Price₹34.99
Market Cap₹18 Cr
BSE Code531099
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Distributors
P/E Ratio12.2
Return on Equity12.67%
Return on Assets0.83%
52-Week Range₹28.42 – ₹138.75
1-Year Price Change-53.2%
3-Month Price Change-35.9%
Beta (1Y)0.95
HeadquartersMumbai, Maharashtra
Websitewww.rubramed.com

Shareholding and Delivery

Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Rubra Medicaments Ltd.

Checkpoint Trends Limited engages in the trading business in India. It also provides management and other consultancy services. The company was formerly known as Rubra Medicaments Limited and changed its name to Checkpoint Trends Limited in May 2022. Checkpoint Trends Limited was incorporated in 1991 and is based in Mumbai, India.

Products and Services

1. Pharmaceuticals-This segment engages in the manufacture and sale of pharmaceutical formulations.

Business Segments

1. Tobacco Products-13.3% 2. Fmcg Products-86.7% 3. Unallocable-0%

Rubra Medicaments Ltd. vs Peers — Health Care Distributors

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Trimurthi Ltd₹197 Cr57.67.99%—+33.3%
Achyut Healthcare Ltd₹191 Cr609.20.95%—+39.7%
Vaidya Sane Ayurved Laboratories₹148 Cr—13.40%—-46.6%
Balaxi Pharmaceuticals Ltd₹125 Cr92.20.59%₹81 Cr-44.5%
Medico Intercontinental Ltd₹25 Crn/m-27.14%₹14 Cr-31.5%
Zenlabs Ethica Ltd₹19 Crn/m-20.44%—-12.5%
Rubra Medicaments Ltd.₹18 Cr12.212.67%—-53.2%
Nexus Surgical & Medicare Ltd₹15 Cr2051.41%—+76.5%
Brawn Biotech Ltd.₹7 Cr724.43%—+9.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Rubra Medicaments Ltd.?

Rubra Medicaments Ltd. is trading at ₹34.99, with a market capitalisation of ₹18 Cr.

Which sector does Rubra Medicaments Ltd. belong to?

Rubra Medicaments Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).

What are the key financial ratios of Rubra Medicaments Ltd.?

Rubra Medicaments Ltd. has a P/E of 12.2 and a return on equity of 12.67%.

What is the stock symbol of Rubra Medicaments Ltd.?

Rubra Medicaments Ltd. is listed on the BSE under the scrip code 531099.

How has Rubra Medicaments Ltd.'s share price moved over the past year?

Rubra Medicaments Ltd.'s share price is down 53.2% over one year and down 35.9% over three months. Its 52-week range is ₹28.42 to ₹138.75.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.